SEC INSIDER TRANSACTIONS

THERMO FISHER SCIENTIFIC INC. (TMO) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TMO · THERMO FISHER SCIENTIFIC INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 40 filings · fetched 2026-11-13T20:19:33Z

Recent reported activity

0purchase rows on this page

19sale rows on this page

165matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-07Filed 2026-08-10	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $583.01 to $584.00, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12) and (13) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $584.01 to $584.93, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.05 to $586.04, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $586.05 to $586.88, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $587.37 to $587.91, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.21 to $590.06, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.40 to $590.98, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $593.22 to $593.36, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.26 to $579.27, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.71 to $580.72, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $581.85 to $581.86, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $583.01 to $584.00, inclusive. F14 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. F15 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. References:	M Exercise / conversionCommon Stock · Non-derivative	275A	309.63	Direct	Form 4 ↗0001216055-26-000009
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F20	M Exercise / conversionStock Option (Right to Buy) · Derivative	10,000D	0	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F19	S Sale (market/private)Common Stock · Non-derivative	127D	580.01	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F18	S Sale (market/private)Common Stock · Non-derivative	119D	578.93	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F17	S Sale (market/private)Common Stock · Non-derivative	361D	577.57	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F16	S Sale (market/private)Common Stock · Non-derivative	225D	576.09	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F15	S Sale (market/private)Common Stock · Non-derivative	1,060D	575.41	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F14	S Sale (market/private)Common Stock · Non-derivative	1,008D	574.28	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F13	S Sale (market/private)Common Stock · Non-derivative	1,200D	573.34	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F12	S Sale (market/private)Common Stock · Non-derivative	660D	572.33	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F11	S Sale (market/private)Common Stock · Non-derivative	240D	571	IndirectBy Floral Park Associates, Inc.	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F10	S Sale (market/private)Common Stock · Non-derivative	311D	579.9	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F9	S Sale (market/private)Common Stock · Non-derivative	321D	578.67	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F8	S Sale (market/private)Common Stock · Non-derivative	451D	577.43	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F7	S Sale (market/private)Common Stock · Non-derivative	480D	576.46	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F6	S Sale (market/private)Common Stock · Non-derivative	2,164D	575.46	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F5	S Sale (market/private)Common Stock · Non-derivative	1,617D	574.4	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	2,545D	573.53	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	1,631D	572.43	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	480D	571.05	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive. F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive. F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive. F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive. F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive. F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive. F20 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References:	M Exercise / conversionCommon Stock · Non-derivative	10,000A	309.63	Direct	Form 4 ↗0001216055-26-000007
2026-08-06Filed 2026-08-07	Britt Lisa P.Officer · Sr. VP and Chief HR Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. References: F1	M Exercise / conversionStock Option (Right to Buy) · Derivative	5,850D	0	Direct	Form 4 ↗0000097745-26-000146
2026-08-06Filed 2026-08-07	Britt Lisa P.Officer · Sr. VP and Chief HR Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. References:	S Sale (market/private)Common Stock · Non-derivative	5,850D	580	Direct	Form 4 ↗0000097745-26-000146
2026-08-06Filed 2026-08-07	Britt Lisa P.Officer · Sr. VP and Chief HR Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. References:	M Exercise / conversionCommon Stock · Non-derivative	5,850A	309.63	Direct	Form 4 ↗0000097745-26-000146
2026-08-05Filed 2026-08-07	CASPER MARC NDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.86 to $566.63, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) and (14) to this Form 4. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.42 to $568.36, inclusive. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.56 to $569.55, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.18 to $572.03, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.36 to $573.34, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.45 to $574.42, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.48 to $575.47, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.48 to $576.47, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.48 to $577.42, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.49 to $577.63, inclusive. F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.86 to $566.63, inclusive. F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.55 to $569.50, inclusive. F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.55 to $569.76, inclusive. F15 The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4. References: F15	M Exercise / conversionStock Option (Right to Buy) · Derivative	10,000D	0	Direct	Form 4 ↗0001216055-26-000006

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.